vs

Side-by-side financial comparison of Scilex Holding Co (SCLX) and VerifyMe, Inc. (VRME). Click either name above to swap in a different company.

VerifyMe, Inc. is the larger business by last-quarter revenue ($5.0M vs $4.8M, roughly 1.1× Scilex Holding Co). VerifyMe, Inc. runs the higher net margin — -66.7% vs -961.9%, a 895.2% gap on every dollar of revenue. On growth, VerifyMe, Inc. posted the faster year-over-year revenue change (-7.4% vs -67.8%). Over the past eight quarters, VerifyMe, Inc.'s revenue compounded faster (-5.2% CAGR vs -33.6%).

Scilex Holding Co is a commercial-stage biopharmaceutical firm focused on developing and commercializing innovative non-opioid pain management therapies for acute and chronic pain segments. It primarily serves the US market, offering prescription and over-the-counter pain relief solutions for patients and healthcare providers.

VerifyMe, Inc. is a technology provider specializing in identity verification, anti-counterfeiting, and brand protection solutions. Its offerings include secure authentication tools, supply chain traceability systems, and customer engagement platforms, serving consumer goods, pharmaceutical, and retail sectors across North America and select global markets.

SCLX vs VRME — Head-to-Head

Bigger by revenue
VRME
VRME
1.1× larger
VRME
$5.0M
$4.8M
SCLX
Growing faster (revenue YoY)
VRME
VRME
+60.4% gap
VRME
-7.4%
-67.8%
SCLX
Higher net margin
VRME
VRME
895.2% more per $
VRME
-66.7%
-961.9%
SCLX
Faster 2-yr revenue CAGR
VRME
VRME
Annualised
VRME
-5.2%
-33.6%
SCLX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
SCLX
SCLX
VRME
VRME
Revenue
$4.8M
$5.0M
Net Profit
$-46.1M
$-3.4M
Gross Margin
45.5%
41.2%
Operating Margin
-2317.8%
-68.2%
Net Margin
-961.9%
-66.7%
Revenue YoY
-67.8%
-7.4%
Net Profit YoY
-613.7%
-38.4%
EPS (diluted)
$-4.63
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SCLX
SCLX
VRME
VRME
Q4 25
$4.8M
Q3 25
$10.6M
$5.0M
Q2 25
$9.9M
$4.5M
Q1 25
$5.0M
$4.5M
Q4 24
$14.9M
Q3 24
$14.4M
$5.4M
Q2 24
$16.4M
$5.4M
Q1 24
$10.9M
$5.8M
Net Profit
SCLX
SCLX
VRME
VRME
Q4 25
$-46.1M
Q3 25
$-257.8M
$-3.4M
Q2 25
$-44.0M
$-291.0K
Q1 25
$-26.1M
$-571.0K
Q4 24
$-6.5M
Q3 24
$-4.4M
$-2.4M
Q2 24
$-37.6M
$-346.0K
Q1 24
$-24.4M
$-553.0K
Gross Margin
SCLX
SCLX
VRME
VRME
Q4 25
45.5%
Q3 25
68.5%
41.2%
Q2 25
66.9%
35.2%
Q1 25
72.3%
33.4%
Q4 24
68.5%
Q3 24
73.9%
34.9%
Q2 24
73.2%
39.1%
Q1 24
64.7%
39.2%
Operating Margin
SCLX
SCLX
VRME
VRME
Q4 25
-2317.8%
Q3 25
-1766.2%
-68.2%
Q2 25
-207.2%
-7.1%
Q1 25
-557.5%
-13.3%
Q4 24
-190.5%
Q3 24
-138.0%
-52.8%
Q2 24
-95.4%
-10.0%
Q1 24
-179.0%
-11.2%
Net Margin
SCLX
SCLX
VRME
VRME
Q4 25
-961.9%
Q3 25
-2441.5%
-66.7%
Q2 25
-445.1%
-6.4%
Q1 25
-521.2%
-12.8%
Q4 24
-43.4%
Q3 24
-30.4%
-44.6%
Q2 24
-229.6%
-6.5%
Q1 24
-224.0%
-9.6%
EPS (diluted)
SCLX
SCLX
VRME
VRME
Q4 25
$-4.63
Q3 25
$-22.17
$-0.26
Q2 25
$-7.42
$-0.02
Q1 25
$-2.26
$-0.05
Q4 24
$8.53
Q3 24
$-0.58
$-0.23
Q2 24
$-7.67
$-0.03
Q1 24
$-8.33
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SCLX
SCLX
VRME
VRME
Cash + ST InvestmentsLiquidity on hand
$5.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$-207.8M
$11.1M
Total Assets
$365.0M
$13.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SCLX
SCLX
VRME
VRME
Q4 25
$5.0M
Q3 25
$878.0K
Q2 25
$4.1M
Q1 25
$5.8M
Q4 24
$3.3M
Q3 24
$77.0K
$2.6M
Q2 24
$6.9M
$2.9M
Q1 24
$1.8M
$2.8M
Total Debt
SCLX
SCLX
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$500.0K
Q2 24
$600.0K
Q1 24
$800.0K
Stockholders' Equity
SCLX
SCLX
VRME
VRME
Q4 25
$-207.8M
Q3 25
$-176.9M
$11.1M
Q2 25
$-249.0M
$14.4M
Q1 25
$-211.5M
$14.6M
Q4 24
$-192.6M
Q3 24
$-211.3M
$10.3M
Q2 24
$-214.7M
$12.3M
Q1 24
$-189.8M
$12.4M
Total Assets
SCLX
SCLX
VRME
VRME
Q4 25
$365.0M
Q3 25
$275.9M
$13.3M
Q2 25
$83.8M
$17.2M
Q1 25
$79.0M
$17.1M
Q4 24
$93.0M
Q3 24
$100.4M
$14.8M
Q2 24
$104.5M
$17.5M
Q1 24
$91.2M
$17.9M
Debt / Equity
SCLX
SCLX
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SCLX
SCLX
VRME
VRME
Operating Cash FlowLast quarter
$-17.5M
$243.0K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SCLX
SCLX
VRME
VRME
Q4 25
$-17.5M
Q3 25
$8.2M
$243.0K
Q2 25
$7.0M
$710.0K
Q1 25
$6.0M
$-404.0K
Q4 24
$2.5M
Q3 24
$5.1M
$-10.0K
Q2 24
$2.3M
$372.0K
Q1 24
$9.4M
$-60.0K
Free Cash Flow
SCLX
SCLX
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-12.0K
Q2 24
$369.0K
Q1 24
$-62.0K
FCF Margin
SCLX
SCLX
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.2%
Q2 24
6.9%
Q1 24
-1.1%
Capex Intensity
SCLX
SCLX
VRME
VRME
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
0.0%
Q2 24
0.1%
Q1 24
0.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SCLX
SCLX

Segment breakdown not available.

VRME
VRME

Proactive Services$4.2M83%
Other$869.0K17%

Related Comparisons